Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study
在炎症性肠病患者中,从原研英夫利昔单抗双重转换至生物类似药CT-P13和SB2的安全性和临床疗效(SCESICS):一项多中心队列研究
期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.13131
Mazza, Stefano; Piazza O Sed, Nicole; Conforti, Francesco Simone; Fascì, Alberto; Rimondi, Alessandro; Marinoni, Beatrice; Casini, Valentina; Ricci, Chiara; Munari, Francesca; Pirola, Lorena; Invernizzi, Pietro; Girelli, Carlo; Lupinacci, Guido; Pastorelli, Luca; Cavallaro, Flaminia; Ferraris, Luca; Colucci, Alice; Amato, Arnaldo; Eugenio Tontini, Gian; Vecchi, Maurizio; Fiorino, Gionata; Caprioli, Flavio